Genital Herpes - Market Insights, Epidemiology and Market Forecast-2023

Publisher Name :
Date: 01-Jan-2017
No. of pages: 100
Price : Single User: US $ 4950  US $ 4208 Corporate User: US $ 14850  US $ 10395
This report is available at 15% Discount for Single User License and 30% Discount for Corporate Users License till 30 June 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's Genital Herpes - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Crohn's disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Genital Herpes forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Genital Herpes till 2023.

Key Coverage and Benefits

  • The report will help in developing business strategies by understanding the trends shaping and driving the global Genital Herpes market.

  • Identifying patient populations in the global "Genital Herpesmarket to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Genital Herpes therapeutics in each of the markets covered.

  • To understand the future market competition in the global Genital Herpes therapeutics market and Insightful review of the key market drivers and barriers.

Scope

  • Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.

  • Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.

  • The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.

  • It also provides Genital Herpes for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

This report is available at 15% Discount for Single User License and 30% Discount for Corporate Users License till 30 June 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Genital Herpes - Market Insights, Epidemiology and Market Forecast-2023

Table of Contents

Genital Herpes overview
Pathophysiology
Symptoms of disease
Etiology of disease
Diagnosis of disease
Treatment of disease
Overview of Marketed drugs
Drug Description
Mechanism of Action
Pharmacokinetics Properties
Marketed Details
Patent Information
Patent Exclusivity Expiry Assessment United States (US)
Patents Details
Historical and Forecasted sales of marketed molecules in the Global Genital Herpes Market
Global Epidemiology of Genital Herpes Forecasted to 2023
Global Market (2013-2015)
Global Forecasted Market (2016-2023)
Global Market by Geography
Market of US (2013-2015)
Forecasted Market of US (2016-2023)
Market of Europe
Market of Germany (2013-2015)
Forecasted Market of Germany (2016-2023)
Market of United Kingdom (2013-2015)
Forecasted Market of United Kingdom (2016-2023)
Market of France (2013-2015)
Forecasted Market of France (2016-2023)
Market of Italy (2013-2015)
Forecasted Market of Italy (2016-2023)
Market of Spain (2013-2015)
Forecasted Market of Spain (2016-2023)
Market of Japan (2013-2015)
Forecasted Market of Japan (2016-2023)
Market of ROW (2013-2015)
Forecasted Market of ROW (2016-2023)
Appendix
Report Methodology
Consulting Services
Disclaimer
Report Purchase Options
About DelveInsight

List of Tables

Table 1: Drug Description
Table 2: Drug, Marketed Details United States (US)
Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
Table 4: Drug, Patent Details for US
Table 5: Genital Herpes Drug Sales (USD Millions)-2023
Table 6: Global Epidemiology of Genital Herpes (2013-2023)
Table 7: Genital Herpes Global Market (USD Millions), (2013-2015)
Table 8: Genital Herpes Global Market (USD Millions), (2016-2023)
Table 9: Genital Herpes US Market (USD Millions), (2013-2015)
Table 10: Genital Herpes US Market (USD Millions), (2016-2023)
Table 11: Genital Herpes Germany Market (USD Millions), (2013-2015)
Table 12: Genital Herpes Germany Market (USD Millions), (2016-2023)
Table 13: Genital Herpes United Kingdom Market (USD Millions), (2013-2015)
Table 14: Genital Herpes United Kingdom Market (USD Millions), (2016-2023)
Table 15: Genital Herpes France Market (USD Millions), (2013-2015)
Table 16: Genital Herpes France Market (USD Millions), (2016-2023)
Table 17: Genital Herpes Italy Market (USD Millions), (2013-2015)
Table 18: Genital Herpes Italy Market (USD Millions), (2016-2023)
Table 19: Genital Herpes Spain Market (USD Millions), (2013-2015)
Table 20: Genital Herpes Spain Market (USD Millions), (2016-2023)
Table 21: Genital Herpes Japan Market (USD Millions), (2013-2015)
Table 22: Genital Herpes Japan Market (USD Millions), (2016-2023)
Table 23: Genital Herpes ROW Market (USD Millions), (2013-2015)
Table 24: Genital Herpes ROW Market (USD Millions), (2016-2023)

List of Figures

Figure 1: Genital Herpes Drug Sales (USD Millions)-2023
Figure 2: Global Epidemiology of Genital Herpes (2013-2023)
Figure 3: Genital Herpes Global Market (USD Millions), (2013-2015)
Figure 4: Genital Herpes Global Market (USD Millions), (2016-2023)
Figure 5: Genital Herpes US Market (USD Millions), (2013-2015)
Figure 6: Genital Herpes US Market (USD Millions), (2016-2023)
Figure 7: Genital Herpes Germany Market (USD Millions), (2013-2015)
Figure 8: Genital Herpes Germany Market (USD Millions), (2016-2023)
Figure 9: Genital Herpes United Kingdom Market (USD Millions), (2013-2015)
Figure 10: Genital Herpes United Kingdom Market (USD Millions), (2016-2023)
Figure 11: Genital Herpes France Market (USD Millions), (2013-2015)
Figure 12: Genital Herpes France Market (USD Millions), (2016-2023)
Figure 13: Genital Herpes Italy Market (USD Millions), (2013-2015)
Figure 14: Genital Herpes Italy Market (USD Millions), (2016-2023)
Figure 15: Genital Herpes Spain Market (USD Millions), (2013-2015)
Figure 16: Genital Herpes Spain Market (USD Millions), (2016-2023)
Figure 17: Genital Herpes Japan Market (USD Millions), (2013-2015)
Figure 18: Genital Herpes Japan Market (USD Millions), (2015-2023)
Figure 19: Genital Herpes ROW Market (USD Millions), (2013-2015)
Figure 20: Genital Herpes ROW Market (USD Millions), (2016-2023)

  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Chlamydia Infections - Pipeline Review, H1 2017
    Published: 28-Apr-2017        Price: US 2000 Onwards        Pages: 66
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chlamydia Infections - Pipeline Review, H1 2017, provides an overview of the Chlamydia Infections (Infectious Disease) pipeline landscape. Chlamydia is a sexually transmitted infection caused by a bacterium. Symptoms include burning feeling during urination, discharge from the penis or vagina, pain in the lower abdomen, bleeding between periods and pain and swelling around the testicles. Predisposing f......
  • Global Sexually Transmitted Diseases Partnering 2010-2017
    Published: 01-Apr-2017        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the sexually transmitted diseases partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Sexually Transmitted Diseases Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in part......
  • Genital Herpes - Pipeline Review, H1 2017
    Published: 22-Mar-2017        Price: US 2000 Onwards        Pages: 102
    Genital Herpes - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Genital Herpes - Pipeline Review, H1 2017, provides an overview of the Genital Herpes (Infectious Disease) pipeline landscape. Genital herpes is a common sexually transmitted infection that affects both men and women. Genital herpes is caused by the herpes simplex virus (HSV). Symptoms include decreased appetite, fever,......
  • Gonorrhea - Pipeline Review, H1 2017
    Published: 15-Mar-2017        Price: US 2000 Onwards        Pages: 46
    Gonorrhea - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gonorrhea - Pipeline Review, H1 2017, provides an overview of the Gonorrhea (Infectious Disease) pipeline landscape. Gonorrhea is an infection caused by a sexually transmitted bacterium that can infect both males and females. Gonorrhea most often affects the urethra, rectum or throat. In females, gonorrhea can also infect the ......
  • Bacterial Vaginosis - Pipeline Review, H1 2017
    Published: 28-Feb-2017        Price: US 2000 Onwards        Pages: 47
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bacterial Vaginosis - Pipeline Review, H1 2017, provides an overview of the Bacterial Vaginosis (Infectious Disease) pipeline landscape.Bacterial vaginosis (BV), also known as vaginal bacteriosis is a type of vaginal inflammation caused by overgrowth of bacteria present in vagina. Symptoms include vaginal itching; burning during urination and vaginal discharge may become watery and thin. Treatment includes ant......
  • Genital Herpes-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Jan-2017        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Genital Herpes-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Genital Herpes Report is to understand the market and pipeline status of the drugs around the Genital Herpes to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on desi......
  • Gonorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Jan-2017        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Gonorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Gonorrhea Report is to understand the market and pipeline status of the drugs around the Gonorrhea to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline ......
  • Bacterial Vaginosis-Pipeline Insights, 2017
    Published: 01-Jan-2017        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Bacterial Vaginosis-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Bacterial Vaginosis. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acq......
  • Syphilis-API Insights, 2017
    Published: 01-Jan-2017        Price: US 1250 Onwards        Pages: 60
    The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs